Skip to content

News

IPO in the works at Albertsons

Albertsons Cos., the nation’s second-largest supermarket company and one of the biggest retail pharmacy operators, plans to go public. The company filed a registration statement last month with the Securities and Exchange Commission for an initial public offering of common stock.

Consolidation hits health insurance industry

Chain drug retailers have gotten used to dealing with fewer, and larger, drug makers, wholesalers and pharmacy benefit managers over the years. Retailers themselves have also consolidated, and now a merger wave has washed over the health insurance industry.

Medicine Take-Back Campaign under way in Canada

Shoppers Drug Mart (SDM) and the Partnership for a Drug-Free Canada (PDFC) are collaborating on the third National Medicine Take-Back Campaign, to be held through December 2015, and a new partnership with Loblaw Pharmacy will increase the number of pharmacies participating in the campaign to 1,800 n

ACA survives Supreme Court challenge

The Affordable Care Act has survived its second Supreme Court challenge, with a divided court agreeing with the Obama administration that government subsidies that make health insurance affordable for millions of poor and middle-class Americans should be available ­nationwide.

Walgreens loyalty plan promotes health

Walgreen Co. says that its Balance Rewards for healthy choices (BRhc) program, which awards loyalty points for healthy behaviors and activities, is helping members lose weight and driving better medication adherence among participants with hypertension and/or diabetes.

Rite Aid finalizes the acquisition of EnvisionRx

Rite Aid has completed its acquisition of Envision Pharmaceutical Services from private investment firm TPG and other shareholders in a transaction valued at about $2 billion, including about $1.8 billion in cash, and around 27.9 million Rite Aid shares.

New digital innovation lab at CVS will focus on health

CVS Health has officially opened its Digital Innovation Lab, a facility focused on developing cutting-edge services and personalized capabilities for an accessible and integrated pharmacy and health experience. The lab will be a hub for the company’s rapidly growing digital team.

Diplomat buys specialty pharmacy

Diplomat Pharmacy Inc. has acquired Burman’s Specialty Pharmacy in an $82.8 million deal. Burman’s, based in Pennsylvania, is a provider of individualized patient care with a primary focus on hepatitis C.